# Argentina Export Playbook for Europe

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks regional export playbook

Compare buyer markets, access conditions, and calculated product opportunities in Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.

## Navigation

- [Yugalinks home](https://www.yugalinks.com/)
- [Trade data](https://www.yugalinks.com/trade/)
- [Open country workspace](https://www.yugalinks.com/app/countries)
- [Data sources](https://www.yugalinks.com/data-sources)
- [Methodology](https://www.yugalinks.com/methodology)

## Overview

- Exporter: Argentina (ARG)
- Region: Europe
- Latest trade year: 2024
- Buyer markets: 22
- Calculated three-year opportunity: $839.0B
- Reported FTA markets: 0
- Average reported distance: 11,140 km
- Average business entry indicator: 11 days

## Market comparison

| Market | ISO3 | Opportunity | Products | FTA | Distance | Entry days | Top product |
| --- | --- | ---: | ---: | --- | ---: | ---: | --- |
| Germany | DEU | $193.1B | 62 | Not reported | 11,512 km | 8 | Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) |
| United Kingdom | GBR | $129.0B | 31 | Not reported | 11,147 km | 5 | Metals: gold, non-monetary, unwrought (but not powder) |
| Netherlands | NLD | $110.1B | 26 | Not reported | 11,467 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Switzerland, Liechtenstein | CHE | $79.1B | 10 | Not reported | 11,215 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| France | FRA | $76.1B | 26 | Not reported | 11,072 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Belgium | BEL | $48.1B | 11 | Not reported | 11,327 km | 5 | Product not reported |
| Spain | ESP | $37.9B | 17 | Not reported | 10,066 km | 13 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Italy | ITA | $36.4B | 15 | Not reported | 11,174 km | 11 | Heterocyclic compounds: n.e.c. in headings no. 2933 |
| Slovenia | SVN | $35.9B | 5 | Not reported | 11,581 km | 8 | Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof |
| Russia | RUS | $19.3B | 6 | Not reported | 13,505 km | 10 | Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc |
| Czechia | CZE | $19.1B | 9 | Not reported | 11,837 km | 25 | Telephones for cellular networks or for other wireless networks |
| Poland | POL | $17.9B | 10 | Not reported | 12,352 km | 37 | Telephones for cellular networks or for other wireless networks |
| Austria | AUT | $8.5B | 5 | Not reported | 11,834 km | 21 | Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions |
| Ireland | IRL | $7.9B | 2 | Not reported | 11,013 km | 11 | Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg |
| Slovakia | SVK | $5.0B | 3 | Not reported | 11,880 km | 22 | Telephones for cellular networks or for other wireless networks |
| Romania | ROU | $3.7B | 2 | Not reported | 0 km | 0 | Vehicles: parts, gear boxes |
| Denmark | DNK | $2.6B | 2 | Not reported | 12,089 km | 4 | Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale |
| Malta | MLT | $2.6B | 1 | Not reported | 10,907 km | 21 | Commodities not specified according to kind |
| Sweden | SWE | $2.4B | 2 | Not reported | 12,585 km | 8 | Product not reported |
| Hungary | HUN | $1.8B | 1 | Not reported | 11,957 km | 7 | Telephones for cellular networks or for other wireless networks |
| Ukraine | UKR | $1.4B | 1 | Not reported | 12,846 km | 7 | Product not reported |
| Greece | GRC | $1.1B | 1 | Not reported | 11,711 km | 4 | Product not reported |

## Product and market opportunities

| Rank | Market | Product | Opportunity | Buyer growth | Current share |
| ---: | --- | --- | ---: | ---: | ---: |
| 1 | Switzerland, Liechtenstein (CHE) | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $27.7B | +12.3% | +0.0% |
| 2 | United Kingdom (GBR) | HS 710812 - Metals: gold, non-monetary, unwrought (but not powder) | $26.0B | +15.3% | +0.2% |
| 3 | Germany (DEU) | HS 850760 - Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) | $19.8B | +19.2% | +0.0% |
| 4 | Netherlands (NLD) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $18.3B | +6.5% | +0.3% |
| 5 | Switzerland, Liechtenstein (CHE) | HS 710813 - Metals: gold, semi-manufactured | $17.2B | +14.3% | +0.0% |
| 6 | Germany (DEU) | HS 271121 - Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $16.4B | +4.2% | +0.0% |
| 7 | Switzerland, Liechtenstein (CHE) | HS 710812 - Metals: gold, non-monetary, unwrought (but not powder) | $15.0B | +12.8% | +1.8% |
| 8 | United Kingdom (GBR) | HS 270900 - Oils: petroleum oils and oils obtained from bituminous minerals, crude | $14.3B | +5.5% | +0.1% |
| 9 | Belgium (BEL) | HS 271019 - Product description unavailable | $12.8B | +9.1% | +0.0% |
| 10 | Germany (DEU) | HS 271019 - Product description unavailable | $12.3B | +5.8% | +0.0% |
| 11 | Russia (RUS) | HS 870323 - Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc | $12.3B | +12.7% | +0.0% |
| 12 | Netherlands (NLD) | HS 271019 - Product description unavailable | $11.9B | +12.2% | +0.0% |
| 13 | Slovenia (SVN) | HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $11.3B | +34.8% | +0.0% |
| 14 | Slovenia (SVN) | HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $10.5B | +30.0% | +0.0% |
| 15 | United Kingdom (GBR) | HS 870380 - Vehicles: with only electric motor for propulsion | $10.2B | +40.0% | +0.0% |
| 16 | Slovenia (SVN) | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.7B | +17.9% | +0.0% |
| 17 | Germany (DEU) | HS 851712 - Telephones for cellular networks or for other wireless networks | $9.7B | +9.2% | +0.0% |
| 18 | Germany (DEU) | HS 847130 - Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $8.4B | +3.5% | +0.0% |
| 19 | Belgium (BEL) | HS 300220 - Vaccines: for human medicine | $8.0B | +20.4% | +0.0% |
| 20 | Netherlands (NLD) | HS 847130 - Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $7.3B | +4.0% | +0.0% |

## Sector opportunities

| Sector | Products | Reported buyer imports | Opportunity | Average growth |
| --- | ---: | ---: | ---: | ---: |
| HS2 30 - HS2 sector 30 | 43 | $311.8B | $154.5B | +12.2% |
| HS2 85 - HS2 sector 85 | 42 | $218.2B | $127.8B | +11.5% |
| HS2 87 - HS2 sector 87 | 37 | $208.2B | $93.8B | +11.6% |
| HS2 27 - HS2 sector 27 | 12 | $193.2B | $85.0B | +9.3% |
| HS2 00 - HS2 sector 00 | 20 | $197.8B | $84.5B | +8.1% |
| HS2 71 - HS2 sector 71 | 11 | $218.1B | $79.6B | +10.6% |
| HS2 84 - HS2 sector 84 | 24 | $109.3B | $71.7B | +8.0% |
| HS2 29 - HS2 sector 29 | 10 | $39.2B | $44.0B | +21.7% |

## Frequently asked questions

### Should Argentina focus on Europe?

Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.

### What does calculated opportunity mean?

It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.

### How should exporters use this page?

Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, tariffs, standards, logistics, pricing, and competition before acting.

Yugalinks presents derived views for research and planning. [Read the full methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.